A panel of F.D.A. advisers is set to discuss Merck’s Covid pill.

Health
By BY REBECCA ROBBINS AND CARL ZIMMER from NYT Health https://ift.tt/3lnhk2t
via IFTTT Molnupiravir (Drug), Coronavirus (2019-nCoV), Coronavirus Omicron Variant, Vaccination and Immunization If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda